Blake AI | Deterministic AI for Defence, Healthcare & Industry
Invest in Blake AI | Deterministic AI for Defence, Healthcare & Industry
Investing in Deterministic AI
Blake AI is building the AI infrastructure layer for industries where "probably correct" isn't good enough. We're raising £1.5M Seed Round to take our deterministic physics engine from R&D to pilot stage across UK and EU defence and healthcare markets.
The Problem
Regulators, clinicians, and procurement teams in these sectors increasingly require auditable, repeatable, explainable outputs, and most AI vendors structurally cannot provide that, because their underlying models are probabilistic by design.
Most AI today is probabilistic - it produces a statistically likely answer, not a guaranteed one. That's acceptable for a chatbot. It's not acceptable for:
A clinical decision support tool
A defence targeting or surveillance system
An industrial safety-critical control system
The Solution
Blake AI's core engine is built on deterministic, physics-grounded computation rather than probabilistic inference.
Two arms bring this to market:
- VRU - the IP layer: deterministic physics models, digital twin simulation, detection systems
- VRGO - the services layer: consultancy, hardware integration, deployment
This dual structure means Blake AI can capture both software licensing revenue and consultancy/services revenue from the same core technology.
Market Opportunity
The category Blake AI competes in, explainable, auditable AI, sits inside a much larger AI market, and is growing fast in its own right.
Total Addressable Market (TAM):
Within the global AI in Aerospace & Defense market is projected to grow from £19.4B (2024) to £34.0B by 2030. The global AI in Healthcare market is projected to reach £148.3B by 2030. (Grand View Research) Combined, this represents a TAM approaching £182.7B by 2030 across Blake AI's two core target sectors.
Serviceable Addressable Market (SAM):
Within the Explainable AI market, Blake AI's direct category is projected to grow from £6.15B (2024) to £16.63B by 2030, an 18% Compound Annual Growth Rate (CAGR) (Grand View Research). This is the category investors should track most closely, as it represents the specific demand for deterministic, auditable AI that Blake AI is built to serve.
Serviceable Obtainable Market (SOM):
Blake AI's near-term focus is capturing early design partners and pilot contracts across UK/EU defence and healthcare procurement.
Unlike vendors that layer explainability tooling onto a probabilistic base model, Blake AI's outputs are deterministic by construction - the architecture itself, not an add-on, is what makes results repeatable and auditable.
Why Blake AI Wins
Comparing, Probabilistic AI vendors (LLM-based) vs. Traditional simulation/digital twin vendors vs. Blake AI delivers on Deterministic, repeatable outputs. Blake AI wins by being fully offline, no cloud dependency. Built for regulated/defence-grade use with combined IP + consultancy model.
The Moat
Deterministic architecture, not a wrapper. Built from first principles for repeatable, explainable output, not bolted onto an existing probabilistic model.
Offline-first by design. Full functionality without cloud dependency, critical for defence and secure healthcare environments.
Founder-led scientific credibility. Peer-reviewed research published in Nature, plus 10+ years of R&D across biomedicine, physics, and simulation engineering.
Dual revenue model. VRU (IP/software licensing) and VRGO (consultancy/integration) capture two revenue streams from one core technology.
Traction
IP & Research credibility: Founder-authored peer-reviewed research published in Nature; 10+ years of R&D across biomedicine, physics, and simulation engineering
Product: Deterministic physics engine and digital twin simulation architecture in active development
Early interest: Founders Waitlist open for early access and design partnerships
Status: Pre-pilot, R&D stage - actively seeking first UK/EU defence and healthcare design partners
(We're early-stage and transparent about it. Our strength right now is deep technical and scientific credibility - not yet commercial scale. That's exactly what this raise is for.)
Section 8: The Ask
Raising: £1.5M Seed Round
Stage: R&D to pilot
Geography: UK and EU opportunities welcome
Use of Funds (18-month plan):
- 45% — R&D & Engineering: Complete the deterministic physics engine, digital twin visualisation layer, and live sensor/data integration to pilot-ready state
- 20% — Pilot Delivery: Fund first UK/EU design partner pilots in defence and healthcare, including on-site integration via VRGO
- 10% — Compute & Infrastructure: Hardware, cloud/edge compute, and lab equipment needed for physics model validation at scale
- 10% — IP, Regulatory & Compliance: Patent filing, UK/EU regulatory groundwork, and security accreditation relevant to defence and healthcare procurement
- 8% — Business Development: Building relationships with UK/EU defence and healthcare procurement contacts, pilot partner outreach
- 7% — Operations & Legal: Company structuring across VRU/VRGO, legal and accounting costs
Terms: Open to discussing structure (equity, SAFE, or grant-matched funding) directly with serious investors - every conversation starts with understanding your fund's typical approach before we propose terms.
Founder
Blake Hopley - Founder & CEO
Career spanning biomedicine research (including a peer-reviewed Nature publication), physics and chemistry education, and simulation engineering. Founded Blake AI to bring deterministic, auditable AI to industries where probabilistic models fall short.
Get in Touch
You've seen the opportunity, our traction, and the ask. If Blake AI fits your portfolio, we'd like to talk.
Submit your details below and we'll follow up within 48 hours to arrange a conversation - including deeper technical architecture and IP strategy detail for qualified investors, under NDA where appropriate.